Press release
Increasing Prevalence of Acute Kidney Injury (AKI) and Chronic Kidney Disease to Drive Drug-induced Nephrotoxicity Treatment Market Growth, Says Fact.MR
The growing prevalence of kidney disorders is expected to be the major factor driving the growth of the drug-induced nephrotoxicity treatment market over the forecast period. Increasing geriatric who are more prone drugs toxicity is also one of the key factor which is driving the drug-induced nephrotoxicity treatment. For instance, more than 661,000 American have kidney failure and in 2013 more than 47,000 American died from kidney disease (source: National Institute of Diabetes and Kidney Diseases).The Market Research Survey by "Fact.MR, A Market Research and Competitive Intelligence Provider" highlights the key reasons behind increasing Demand of Drug-induced Nephrotoxicity Treatment. The new Drug-induced Nephrotoxicity Treatment market analysis report outlines the key factors that will impact sales, production and supply during the assessment 2021-203. The report highlights the Drug-induced Nephrotoxicity Treatment market key trends that are expected to influence the overall dynamics, and Drug-induced Nephrotoxicity Treatment market size and share.
To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=1525
Drug-induced Nephrotoxicity Treatment Market: Segmentation
Tentatively, the global drug-induced nephrotoxicity treatment market can be segmented on the basis of biomarker and end users, and geography.
Based on biomarkers, the global drug-induced nephrotoxicity treatment market is segmented as:
Immunoglobulin G
Albumin
Microglobulins
Cystatin C Retinol binding protein
Cytokines
Interferons
Interleukins
N-Acetyl-D-Glucosaminidase
Clusterin
Osteopontin
Kidney Injury Molecule-1 (KIM-1)
Neutrophil gelatinase-associated lipocalin (NGAL)
Based on end users, the global drug-induced
nephrotoxicity treatment market is segmented as:
Pharmaceutical and Biotechnology Companies
Academic Institutes
Research Organizations
Others
* Full Segmentation Available on Demand*
Key questions answered in Drug-induced Nephrotoxicity Treatment Market Survey Report:
What is the current scenario and key trends in Drug-induced Nephrotoxicity Treatment Market?
What are the key strategies companies are adopting to increase their consumer base?
What are the key categories within the Drug-induced Nephrotoxicity Treatment segments and their future potential?
What are the major Drug-induced Nephrotoxicity Treatment Market drivers and their expected impact during the short, medium, and long terms?
What is the Drug-induced Nephrotoxicity Treatment Market size and what are the opportunities for the key players?
Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1525
Essential Takeaways from the Market Report
Comparison of prominent players operating in the market.
Recent developments and key strategies adopted by market players.
Study of the micro and macro-economic growth indicators.
Impact of the various factors on the sales of the Drug-induced Nephrotoxicity Treatment market.
Market share analysis of the key companies in Drug-induced Nephrotoxicity Treatment industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Drug-induced Nephrotoxicity Treatment Market: Key Players
Examples of some of the key players operating in the global drug-induced nephrotoxicity treatment market are Roche Diagnostic Limited, Siemens Healthcare, Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Aushon BioSystem Inc., Epistem Ltd, G.E. Healthcare Inc., and Affymetrix, Inc. Companies are conducting research for the development of new drug-induced nephrotoxicity treatment biomarkers which expected to provide the high growth opportunity for drug-induced nephrotoxicity treatment market.
The Report Covers Exhaustive Analysis On:
Drug-induced Nephrotoxicity Treatment Market Drivers, Segments and Restraints.
Drug-induced Nephrotoxicity Treatment Market Survey and Dynamics
Drug-induced Nephrotoxicity Treatment Market Size & Demand
Drug-induced Nephrotoxicity Treatment Key Trends/Issues/Challenges
Drug-induced Nephrotoxicity Treatment Sales, Competition & Companies involved
Read More Trending and Similar Reports from Fact.MR – http://www.globenewswire.com/en/news-release/2018/02/14/1348050/0/en/7-Key-Takeaways-on-Lifesciences-Data-Mining-and-Visualization-Market-for-Forecast-Period-2017-2026.html
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Prevalence of Acute Kidney Injury (AKI) and Chronic Kidney Disease to Drive Drug-induced Nephrotoxicity Treatment Market Growth, Says Fact.MR here
News-ID: 2360152 • Views: …
More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…

Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…

Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…

Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Nephrotoxicity
Platinum-based Chemotherapy and Nephrotoxicity Market to Reach USD 2.8 Billion b …
Platinum-based chemotherapy-primarily involving cisplatin, carboplatin, and oxaliplatin-remains a cornerstone in the treatment of various solid tumors, including lung, ovarian, testicular, and bladder cancers. These agents are highly effective due to their DNA-damaging mechanisms, but they carry significant risks, notably nephrotoxicity (kidney damage). Nephrotoxicity can manifest as acute kidney injury (AKI) or chronic kidney disease (CKD), often necessitating dose adjustments or discontinuation of therapy, impacting overall treatment outcomes.
Download Full PDF Sample…
Platin Based Chemotherapies And Nephrotoxicity Therapeutics Market Size in the 7 …
DelveInsight's "Platinum-based Chemotherapy and Nephrotoxicity Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Platinum-based Chemotherapy and Nephrotoxicity, historical and forecasted epidemiology as well as the Platinum-based Chemotherapy and Nephrotoxicity trends in the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan.
Discover Key Insights into the Platin based chemotherapies and nephrotoxicity Market with DelveInsight's In-Depth Report @ Platin based chemotherapies…
Booming Demand in the Drug-induced Nephrotoxicity Treatment Market Will Drive an …
Drug-induced Nephrotoxicity Treatment Market research report provides all specific industry data from 2023 to 2030. By providing its clients with accurate data, it also gives a market outlook and aids in the making of crucial decisions. The market is described in general terms, along with its description, uses, advancements, and production technology. This research report on Drug-induced Nephrotoxicity Treatment keeps tabs on all existing market breakthroughs and changes. It provides…
Drug-induced Nephrotoxicity Treatment Market Trends and Forecast Report 2022 | B …
The QY Research released a latest market research report on the global and United States Drug-induced Nephrotoxicity Treatment market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Drug-induced Nephrotoxicity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by…
Drug-induced Nephrotoxicity Treatment Market Value Projected to Expand during 20 …
The market report by Fact.MR envelopes an all-in information of the global Drug-induced Nephrotoxicity Treatment market and the nature of the market growth over the foreseeable period.
The report provides a comprehensive elaboration of the positives and negatives of the global Drug-induced Nephrotoxicity Treatment market with DROT and Porter’s Five Forces analysis.
To Get In-depth Information View Full Report - https://www.factmr.com/report/1525/druginduced-nephrotoxicity-treatment-market
The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence…
Drug-induced Nephrotoxicity Treatment Market Trends, Regulations And Competitive …
Drug-induced nephrotoxicity or drug-induced kidney disease (DIKD) is primarily recognized as a significant contributor to kidney disease including acute kidney injury (AKI) and chronic kidney disease (CKD). Drug-induced nephrotoxicity is often go unrecognized, particularly in the setting of short drug exposures, which leads challenges in assessing the incidence, severity and long-term consequences of drug-induced kidney disease. The mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation,…